What did @barkineris actually say?
Honestly, not much that can be pinned down medically. The transcript here is largely incoherent, likely the result of automated transcription struggling with Turkish speech or background audio. The caption tells the real story: the creator describes hitting a rough patch around month four of testosterone therapy, calling it "maymunlaşıp" (roughly, going through an awkward phase), then recovering by month nine. The hashtags confirm this is an FTM testosterone journey video with voice change before-and-after content.
What we can extract from the caption is a specific timeline claim: that months four through roughly eight were difficult, emotionally and physically, and that month nine brought stabilization. That is a real and documented pattern. The transcript itself does gesture at emotional states, mentioning being depressed, shy, dizzy, and exhausted, which actually maps onto known testosterone adjustment side effects, even if the words came through garbled.
Does the science back this up?
Yes, largely. The "rough middle months" experience this creator describes is well-documented in transgender men on testosterone. The voice change timeline especially follows a predictable arc that peaks in awkwardness before settling.
A 2019 study by Azul et al. published in the Journal of Speech, Language, and Hearing Research found that voice changes in transmasculine individuals on testosterone typically begin within the first one to three months but go through an unstable, cracking phase that can persist through months four to eight before stabilizing. The creator's month four crash and month nine recovery is textbook for this.
On the emotional side, research from Colizzi et al. (2014, Psychoneuroendocrinology) found that testosterone therapy in transgender men showed an initial period of psychological adjustment, with some participants reporting increased irritability, mood dysregulation, and fatigue particularly in the first six months. This matches the creator's description of depression and exhaustion during that window.
The dizziness they mention is less discussed but not surprising. Hematocrit changes from testosterone can affect cardiovascular regulation, and some users report orthostatic symptoms, particularly if dose titration was aggressive early on.
What did they get wrong (or right)?
They got the timeline right. Month four to nine being the hardest stretch before stabilization is consistent with the clinical literature, not just anecdote. That deserves credit.
What is missing is any acknowledgment that individual variation is significant. The creator's timeline is not universal. Some transmasculine people stabilize faster, some slower. Voice changes can take up to two years to fully resolve, according to Nygren et al. (2016, Transgender Health). If viewers take this video as a precise roadmap, they may be unprepared for a different experience.
The emotional symptoms described, including depression and fatigue, are real but also warrant a flag: these can be signs of subtherapeutic dosing, over-dosing, or comorbid mental health conditions that need evaluation, not just waiting out. Framing it as simply a phase you survive could discourage people from flagging these symptoms to their prescribing clinician.
- Voice change timeline: accurate and consistent with research
- Emotional difficulty in mid-therapy: accurate but potentially under-contextualized
- Implicit "just wait it out" framing: mildly concerning if it discourages clinical check-ins
What should you actually know?
The four-to-nine month window on testosterone is real, and it is often harder than people expect going in. Voice changes specifically go through a cracking, inconsistent phase before the pitch drops and stabilizes. This is not a sign something is wrong. It is laryngeal tissue responding to androgen exposure in a non-linear way.
That said, persistent depression, dizziness, and fatigue during testosterone therapy are not things to simply endure. These symptoms should prompt a lab check at minimum. Testosterone levels, hematocrit, estradiol, and hemoglobin are all standard monitoring targets. The Endocrine Society's 2017 clinical practice guidelines for transgender medicine recommend monitoring every three months in the first year for exactly this reason.
If you are on a testosterone protocol and hitting a rough patch emotionally, talk to your prescriber before deciding it is just "part of the process." It might be. It also might be something adjustable.